Recombinant aequorin: A bioluminescent signal for molecular diagnostics

Journal of Clinical Ligand Assay

Volumn 22, Issue 2, 1999, Pages 158-172

  Smith, David F ^a   Stults, Nancy L ^a   Cormier, Milton J ^b   Actor, Jeffrey K ^c  

^a Nippon Chemi Con   (Japan)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Aequorin; AquaLite ; Bioluminescence; Cytokines; Cytomegalovirus; Molecular diagnostics; Non isotopic; Photoprotein; Quantitative PCR; RT PCR

Indexed keywords

AEQUORIN; AQUALITE; CYTOKINE; HAPTEN; OLIGONUCLEOTIDE; PHOTOPROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

BIOLUMINESCENCE; CHEMICAL MODIFICATION; CYTOMEGALOVIRUS; FLUORESCENCE; JELLYFISH; NONHUMAN; NUCLEIC ACID ANALYSIS; PROTEIN DETERMINATION; PROTEIN STABILITY; QUANTUM CHEMISTRY; RADIOIMMUNOASSAY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0032825333     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Jansen EHJM, van den Berg RH, Zomer G: Horseradish peroxidase as a label in chemiluminescent immunoassays, in van Dyke K, van Dyke R (eds): Luminescence Immunoassay and Molecular Applications. Boca Raton, CRC Press, 1990, pp 57-75.
2. Kricka LJ, Thorpe GHG: Bioluminescent and chemiluminescent detection of horseradish peroxidase labels in ligand binder assays, in van Dyke K, van Dyke R (eds): Luminescence Immunoassay and Molecular Applications. Boca Raton, FL, CRC Press, 1990, pp 77-98.
3. Bronstein I: Chemiluminescent 1,2-dioxetane-based enzyme substrates and their applications, in van Dyke K, van Dyke R (eds): Luminescence Immunoassay and Molecular Applications. Boca Raton, FL, CRC Press, 1990, pp 255-274.
4. Weeks I, Beheshti I, McCapra F, et al: Acridinium esters as high-specific activity labels in immunoassay. Clin Chem 1983;29:1474-1479.
5. Weeks I, Sturgess M, Brown RC, et al: Immunoassays using acridinium esters. Methods Enzymol 1986;133:366-387.
6. McCapraF: Chemical mechanisms in bioluminescence. Accounts of Chemical Research 1976;9:201-207.
7. McCapra F, Watmore D, Sumun F, et al: Luminescent labels for immunoassay - from concept to practice. J Biolum Chemilum 1989;4:51-58.
8. Campbell AK: Chemiluminescence: Principles and Applications in Biology and Medicine. Chichester, UK, Ellis Horwood Ltd., 1988, pp 42-50.
9. Cormier MJ: Comparative biochemistry of animal systems, in Herring PJ (ed): Bioluminescence in Action. London, Academic Press. 1978, pp 75-108.
10. McElroy WD, Seliger HH: Mechanism of action of firefly luciferase. Fed Proc 1962;21:1006-1011.
11. Shimomura O, Johnson FH: Calcium binding, quantum yield, and emitting molecule in aequorin bioluminescence. Nature 1970; 227:1356-1357.
12. Hart RC, Matthews JC, Hori R, et al: Renilla reniformis bioluminescence: Luciferase-catalyzed production of nonradiating excited states from luciferin analogues and elucidation of the excited state species involved in energy transfer to Renilla green fluorescent protein. Biochemistry 1979;18:2204-2210.
13. Seliger HH, McElroy WD: The colors of firefly bioluminescence: Enzyme configuration and species specificity. PNAS 1964;52:75-81.
14. Mayerhofer R, Langridge WHR, Cormier MJ, et al: Expression of recombinant Renilla luciferase in transgenic plants results in high levels of light emission. The Plant Journal 1995;7:1031-1036.
15. Lorenz W, Cormier MJ, O'Kane DJ, et al: Expression of the Renilla reniformis luciferase gene in mammalian cells. Bioluminescence and Chemiluminescence 1996;11:31-37.
16. Sherf BA, Navarro SL, Hannah RR, et al: Dual-luciferase reporter assay: An advanced co-reporter technology integrating firefly and Renilla luciferase assays. Promega Notes 1996;57:2.
17. Grentzmann G, Ingramn JA, Kelly PJ, et al: A dual-luciferase reporter system for studying recoding signals. RNA 1998;4:479-486.
18. Stults NL, Stocks NF, Cummings RD, et al: Applications of recombinant bioluminescent proteins as probes for proteins and nucleic acids, in Stanley P, Kricka L (eds): Bioluminescence and Chemiluminescence: Current Status. Chichester, UK, John Wiley and Sons, 1991, pp 533-536.
19. Shimomura O, Johnson FH, Saiga Y: Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J Cellular and Comp Physiol 1962;59:233-240.
20. Shimomura O, Johnson FH: Properties of the bioluminescent protein aequorin. Biochemistry 1969;8:3991-3997.
21. Shimomura O, Johnson FH: Regeneration of the photoprotein aequorin. Nature 1975;256:236-238.
22. Prasher D, McCann RO, Cormier MJ: Cloning and expression of the cDNA coding for aequorin, a bioluminescent calcium-binding protein. Biochem Biophys Res Comm 1985;126:1259-1268.
23. Prasher DC, McCann RO, Longiaru M, et al: Sequence comparisons of complementary DNAs encoding aequorin isotypes. Biochemistry 1987;26:1326-1332.
24. Inouye S, Sakaki Y, Goto T, et al: Expression of apoaequorin complementary DNA in E. coli. Biochemistry 1986;25:8425-8429.
25. Stults NL, Stocks NF, Rivera H, et al: Use of recombinant biotinylated aequorin in microtiter and membrane-based assays: purification of recombinant apoaequorin from Escherichia coli. Biochemistry 1992;31:1433-1442.
26. ™, a calcium triggered photoprotein. SeaLite Sciences, Inc., Norcross, GA, 1994.
27. Kricka LJ: Bioluminescent and chemiluminescent immunoassays. American Clinical Laboratory 1990;9(10):30-32.
28. Bronstein I, McGrath P: Chemiluminescence lights up. Nature 1989;338:599-600.
29. Patel A, Cormier MJ: Calcium-sensitive photoproteins as bioluminescent labels in immunoassay, in Kricka LJ, Stanley PE, Thorpe GHG, Whitehead TP (eds): Analytical Applications of Bioluminescence and Chemiluminescence. New York, Academic Press, 1984, pp 273-276.
30. Zatta P, Nyame K, Cormier MJ, et al: A solid phase assay for β-1,4-galactosyltransferase activity in human serum using recombinant aequorin. Anal Biochem 1991;194:185-191.
31. Mengeling BJ, Smith P, Stults NL, et al: A microplate assay for analysis of solution-phase glycosyltransferase reactions: Determination of kinetic constants. Anal Biochem 1991;199:286-292.
32. Mattox S, Walrath K, Ceiler D, et al: A solid phase assay for the activity of CMPNeuAc:Galβ-4GlcNAc-R α-2,6-sialyltransferase. Anal Biochem 1992;206:430-436.
33. Debose-Boyd R, Nyame K, Smith DF, et al: α1, 4Fucosyltransferase activity in human serum and saliva. Arch Biochem Biophys 1996;335:109-117.
34. Smith DF, Stults NL, Mercer WD: Bioluminescent immunoassays using streptavidin and biotin conjugates of recombinant aequorin. American Biotechnology Laboratory 1995;7:17-20.
35. Stults NL, Rivera HN, Burke-Payne J, et al: Preparation of stable conjugates of recombinant aequorin with proteins and nucleic acids, in Hastings JW, Kricka LJ, Stanley PE (eds): Bioluminescence and Chemiluminescence: Molecular Reporting with Photons. Chichester, UK, John Wiley and Sons, 1997. pp 423-426.
36. +2-binding photoprotein aequorin after cysteine modification. PNAS 1989;86:80-84.
37. Erikaku T, Zenno S, Inouye S: Bioluminescent immunoassay using a monomeric Fab' photoprotein aequorin conjugate. Biochem Biophys Res Commun 1991;174:1331-1336.
38. Hart RC, Scheuer B, RiveraH, et al: A bioluminescent assay capable of detecting <2 attomoles of hTSH in serum using the recombinant calcium-triggered photoprotein, aequorin, in Stanley P, Kricka LJ (eds): Bioluminescence and Chemiluminescence: Current Status. Chichester, UK, John Wiley and Sons, 1993, pp 320-323.
39. Rigl CT, Rivera HN, Patel MT, et al: Bioluminescent immunoassays for endocrine hormones based on AquaLite, a calcium-activated photoprotein. Clin Chem 1995;41(9):1363-1364.
40. Sgoutas DS, Tuten TE, Verras AA, et al: AquaLite bioluminescence assay of thyrotropin in serum evaluated. Clin Chem 1995;41:1637-1643.
41. Cormier MJ: Calmodulin: The regulation of cellular function, in Spiro TG (ed): Calcium in Biology. New York, John Wiley & Sons, Inc., 1983, pp 54-106.
42. Flannagan K, Sanchez-Brambila G, Barnes C, et al: A study of the stability of AquaLite (recombinant aequorin) lyophilized and in solution in various buffers, in Stanley P, Kricka LJ (eds): Bioluminescence and Chemiluminescence: Current Status. Chichester, UK, John Wiley and Sons, 1993, pp 60-63.
43. Weindel K, Stults NL, Rigl CT, et al: Recombinant aequorin is not subject to interference by commonly used drugs and their metabolites, in Campbell A, Kricka LJ, Stanley P (eds): Bioluminescence and Chemiluminescence: Fundamental and Applied Aspects. Chichester, UK, John Wiley and Sons, 1994. pp 353-356.
44. Stults NL, Rivera HN, Ball RT, et al: Bioluminescent hybridization immunoassays for digoxigenin-labeled PCR products based on AquaLite, a calcium-activated photoprotein. J NIH Res 1995;7:74.
45. Smith DF, Stults NL: AquaLite, a bioluminescent label for immunoassay and nucleic acid detection: Quantitative analyses at the attomol level, in Cohn GE, Soper SA, Winston CH (eds): Ultrasensitive Biochemical Diagnosis. Proc SPIE 1996;2680:156-166.
46. Alard P, Lantz O, Sebagh M, et al: Versatile ELISA-PCR assay for mRNA quantitation from a few cells. BioTechniques 1993;15:730-737.
47. Actor JK, Olsen M, Boven LA, et al: A bioluminescent assay using AquaLite for RT-PCR amplified RNA from mouse lung (Application Note). J NIH Res 1996;8:62.
48. Xiao L, Yang C, Nelson CO, et al: Quantitation of RT-PCR amplified cytokine mRNA by aequorin-based bioluminescence immunoassay. J Immunol Methods 1996;199:139-147.
49. Actor JK, Kuffner T, Dezzutti CS, et al: A flash-type bioluminescence immunoassay that is more sensitive than radioimaging: Quantitative detection of cytokine cDNA in activated and resting human cells. J Immunol Methods 1998;211:65-77.
50. Kricka LJ: Chemiluminescent and bioluminescent techniques. Clin Chem 1991;37:1472-1481.
51. Kricka LJ: Ultrasensitive immunoassay techniques. Clinical Biochemistry 1993;26:325-331.
52. Kenten JH, Casadei J, Link J, et al: Rapid electrochemiluminescence assays of polymerase chain reaction products. Clin Chem 1991;37:1626-1632.
53. Siddiqi AM, Jennings VM, Kidd MR, et al: Evaluation of electrochemiluminescence-and bioluminescence-based assays for quantitating specific DNA. Journal of Clinical Laboratory Analysis 1996;10:423-431.
54. ®, the bioluminescent label for immunoassays, gene detection, and molecular diagnostics in Roda A, Pazzagli M, Kricka L, Stanley P (eds) Bioluminescence and Chemiluminescence: Perspectives for the 21st Century. Chichester, UK, John Wiley and Sons, 1998, pp 83-86.
55. Guenthner PC, Hart CE: Quantitative, competitive PCR assay for HIV-1 using a microplate-based detection system. BioTechniques 1998;24:810-816.
56. Piatak JM Jr., Luk KC, Williams B, et al: Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. BioTechniques 1993;14:70-81.
57. Actor JK, Limor JR, Hunter RL: A flexible bioluminescent-quantitative polymerase chain reaction assay for analysis of competitive PCR amplicons. J Clin Lab Anal 1999;13(1):40-47.
58. Freeman WM, Walker S, Vrana KE: Quantitative RT-PCR: Pitfalls and potential. BioTechniques 1999;26:112-122.
59. Wang AM, Creasey AA, Ladner MB, et al: Molecularcloning of the complementary DNA for human tumor necrosis factor. Science 1985;228:149-154.
60. Actor JK, Marshall MA, Eltoum IA, et al: Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation. Eur J Immunol 1994;24:3050-3056.
61. Jennings VM, Actor JK, Hunter RL: Cytokine profile suggesting that cerebral malaria is an encephalitis. Infection and Immunity 1997;65:4883-4887.
62. Jagannath C, Actor JK, Hunter RL: Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric Oxide: Biology and Chemistry 1998;3:174-186.
63. Jagannath C, Pai S. Actor JK, et al: CRL-1072 enhances antimycobacterial activity of human macrophages through interleukin-8. J Interferon and Cytokine Res 1999;19(1):67-76.
64. Xiao L, Owen SM, Rudolph DL, et al: Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis 1998;177:437-445.
65. Babu JS, Kanangat S, Rouse BT: Limitations and modifications of quantitative polymerase chain reaction: Application to measurement of multiple mRNAs present in small amounts of sample RNA. J Immunol Methods 1993;165:207-216.
66. Jennings VM, Lal AA, Hunter RL: Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria. Infect Immun 1998;66:5972-5979.